AUSTIN, Texas, Oct. 3, 2018 /PRNewswire-PRWeb/ -- Dr. Dan Holtzclaw, a dental implant surgeon with offices in Austin, Texas and San Antonio, Texas recently had his research cited by a 500th article in dental literature.
When publishing peer reviewed research, authors cite other previously published articles to support the positions stated in their manuscript. With more than 500 different articles citing research that has been published by Dr. Dan Holtzclaw, he has become one of the most highly cited authors in dental implantology. When asked about this achievement, Dr. Holtzclaw stated, "Having my published research cited as a reference in 500 other scientific manuscripts is amazing. I am very happy that the publications that I and my co-authors have produced over the years are benefiting others in the realm of dental research." The most recent scientific article to cite one of Dr. Holtzclaw's published papers appeared in the journal Clinical Implant Dentistry and Related Research.
With more than 60 scientific articles published in peer reviewed dental journals such as the Journal of the American Dental Association and the Journal of Periodontology, Dr. Holtzclaw is one of the most highly published dental implant clinicians in the United States. To date, his research has focused on dental implants, All-On-4™ style dental implant treatment, amnion-chorion barriers, bone grafting, sinus lifts, and other various dental implant related topics.
About the Doctor Dan Holtzclaw, DDS, MS is a board-certified periodontist who specializes in traditional and complex dental implant surgery. Dr. Holtzclaw currently serves as the Chief Clinical Officer for DIA Dental Implant Centers. Dr. Holtzclaw is an internationally recognized expert on the All-On-4™ immediately loaded dental implant procedure, the NeoArch® immediately loaded dental implant procedure, sinus bone grafting, mandibular ridge splitting, periodontal bone grafting, and amnion-chorion allografts. Dr. Dan Holtzclaw has published more than 60 scientific articles on these topics in industry leading journals such as the Journal of the American Dental Association, the Journal of Periodontology (official journal of the American Academy of Periodontology), Implant Dentistry (official journal of the International Congress of Oral Implantologists), General Dentistry (official journal of the Academy of General Dentistry), and the Compendium of Continuing Dental Education.
For more information about Dr. Dan Holtzclaw and the services or lectures he offers, visit his websites http://www.austindentalimplantcenter.com or http://www.diadentalimplants.com
All-On-4™is a registered trademark of Nobel Biocare®. While Dr. Dan Holtzclaw has lectured for Nobel Biocare® on numerous occasions and the company has featured him and his surgical procedures in their brochures/advertisements, Nobel Biocare® does not endorse/sponsor Dr. Dan Holtzclaw. NeoArch™ is a registered trademark of Neodent®. While Neodent® has featured Dr. Dan Holtzclaw and his surgical procedures in their company media and has had him provide lectures for the company, Neodent® does not endorse/sponsor Dr. Dan Holtzclaw.
SOURCE Holtzclaw Holdings
Advertisement
When publishing peer reviewed research, authors cite other previously published articles to support the positions stated in their manuscript. With more than 500 different articles citing research that has been published by Dr. Dan Holtzclaw, he has become one of the most highly cited authors in dental implantology. When asked about this achievement, Dr. Holtzclaw stated, "Having my published research cited as a reference in 500 other scientific manuscripts is amazing. I am very happy that the publications that I and my co-authors have produced over the years are benefiting others in the realm of dental research." The most recent scientific article to cite one of Dr. Holtzclaw's published papers appeared in the journal Clinical Implant Dentistry and Related Research.
Advertisement
With more than 60 scientific articles published in peer reviewed dental journals such as the Journal of the American Dental Association and the Journal of Periodontology, Dr. Holtzclaw is one of the most highly published dental implant clinicians in the United States. To date, his research has focused on dental implants, All-On-4™ style dental implant treatment, amnion-chorion barriers, bone grafting, sinus lifts, and other various dental implant related topics.
About the Doctor Dan Holtzclaw, DDS, MS is a board-certified periodontist who specializes in traditional and complex dental implant surgery. Dr. Holtzclaw currently serves as the Chief Clinical Officer for DIA Dental Implant Centers. Dr. Holtzclaw is an internationally recognized expert on the All-On-4™ immediately loaded dental implant procedure, the NeoArch® immediately loaded dental implant procedure, sinus bone grafting, mandibular ridge splitting, periodontal bone grafting, and amnion-chorion allografts. Dr. Dan Holtzclaw has published more than 60 scientific articles on these topics in industry leading journals such as the Journal of the American Dental Association, the Journal of Periodontology (official journal of the American Academy of Periodontology), Implant Dentistry (official journal of the International Congress of Oral Implantologists), General Dentistry (official journal of the Academy of General Dentistry), and the Compendium of Continuing Dental Education.
For more information about Dr. Dan Holtzclaw and the services or lectures he offers, visit his websites http://www.austindentalimplantcenter.com or http://www.diadentalimplants.com
All-On-4™is a registered trademark of Nobel Biocare®. While Dr. Dan Holtzclaw has lectured for Nobel Biocare® on numerous occasions and the company has featured him and his surgical procedures in their brochures/advertisements, Nobel Biocare® does not endorse/sponsor Dr. Dan Holtzclaw. NeoArch™ is a registered trademark of Neodent®. While Neodent® has featured Dr. Dan Holtzclaw and his surgical procedures in their company media and has had him provide lectures for the company, Neodent® does not endorse/sponsor Dr. Dan Holtzclaw.
SOURCE Holtzclaw Holdings
